Minnesota Law Review

Note, Evaluating the Integraty of Biotechnology Research Tools: Merck v. Integra and the Scope of 35 U.S.C. § 271(e)(1)

Patents are critical in the biotechnology and pharmaceutical sectors. However, patents have inhibited competition in certain instances. For example, until the 1980s, pioneer drug companies benefited from a de facto “patent term windfall” because generic manufacturers could not begin the regulatory approval process of their generics until after the pioneer drug patent expired. In response, Congress enacted the Hatch-Waxman Act. This legislation included a new infringement exemption, codified at 35 U.S. C. § 271(e)(1), that allows generic companies to begin the approval process before the pioneer patent expires so that generic equivalents can be brought to market upon expiration of the pioneer patent.

Although § 271(e)(1) seems straightforward, courts have slowly expanded the infringement exemption. In the recent decision of Merck v. Integra, the Supreme Court further extended the exemption’s reach, raising questions as to whether biotechnology research tools used to develop new pharmaceuticals are covered by the exemption. This Note argues that biotechnology research tools should not be covered by the exemption because (a) research tools are not “patented inventions” within the meaning of § 271(e)(1), and (b) expanding the exemption to include research tools would remove the economic incentive to develop biotechnology research tools.

:: View PDF

News & Events

  • Fall Submissions Open – Headnotes

    The Minnesota Law Review: Headnotes fall submissions period is open. For more information, please visit our submissions page. Share this: on Twitter on Facebook on Google+

  • Vol. 97 Piece Quoted in Mother Jones Article

    A recent Mother Jones article predicting how the Roberts Court would resolve King v. Burwell draws on How Business Fares in the Supreme Court from Volume 97. You can read the article here. Share this: on Twitter on Facebook on Google+

  • Welcome to De Novo

    For nearly one hundred years, the Minnesota Law Review has been a leader amongst academic legal publications. When Professor Henry J. Fletcher launched the journal in 1917, his goal was simple. It was to “contribute a little something to the systematic growth of the whole law.” Since then, the Law [...]

  • Minnesota Law Review Alum Remembered 45 Years After Death

    Minnesota Law Review alumnus Tom Cranna was honored at the Annual Banquet this Spring, 45 years after his death. Mr. Cranna was remembered for his contributions to the journal, the school, and the positive impact he had on his family and friends. The Devil’s Lake Journal published a memorial which [...]

  • Follow MLR on Twitter!

    The Minnesota Law Review is proud to announce that we are now on Twitter. Follow us @MinnesotaLawRev for information and updates concerning the petition period and deadlines, the opening and closing of article submissions, our 2014 Symposium: Offenders in the Community, and all other news concerning our authors and publications. [...]


cforms contact form by delicious:days